Epratuzumab (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Epratuzumab" in Italian language version.

refsWebsite

Global rank Italian rank

2aacrjournals.org

8,869^th place

7,853^rd place

1cancer.gov

1,684^th place

2,574^th place

1web.archive.org

1^st place

1archive.org

6^th place

8^th place

1doi.org

2^nd place

7^th place

1nih.gov

4^th place

9^th place

aacrjournals.org (Global: 8,869^th place; Italian: 7,853^rd place)

clincancerres.aacrjournals.org

(EN) Epratuzumab, a Humanized Monoclonal Antibody Targeting CD22 — Clin Cancer Res, su clincancerres.aacrjournals.org.
(EN) Dose-Fractionated Radioimmunotherapy in Non-Hodgkin's Lymphoma Using DOTA-Conjugated, 90Y-Radiolabeled, Humanized Anti-CD22 Monoclonal Antibody, Epratuzumab — Clin Cancer Res, su clincancerres.aacrjournals.org.

archive.org (Global: 6^th place; Italian: 8^th place)

DJ. Wallace, K. Kalunian; MA. Petri; V. Strand; FA. Houssiau; M. Pike; B. Kilgallen; S. Bongardt; A. Barry; L. Kelley; C. Gordon, Efficacy and safety of epratuzumab in patients with moderate/severe active systemic lupus erythematosus: results from EMBLEM, a phase IIb, randomised, double-blind, placebo-controlled, multicentre study., in Ann Rheum Dis, gennaio 2013, DOI:10.1136/annrheumdis-2012-202760, PMID 23313811.

cancer.gov (Global: 1,684^th place; Italian: 2,574^th place)

(EN) Definition of epratuzumab - National Cancer Institute Drug Dictionary - National Cancer Institute, su cancer.gov.

doi.org (Global: 2^nd place; Italian: 7^th place)

dx.doi.org

DJ. Wallace, K. Kalunian; MA. Petri; V. Strand; FA. Houssiau; M. Pike; B. Kilgallen; S. Bongardt; A. Barry; L. Kelley; C. Gordon, Efficacy and safety of epratuzumab in patients with moderate/severe active systemic lupus erythematosus: results from EMBLEM, a phase IIb, randomised, double-blind, placebo-controlled, multicentre study., in Ann Rheum Dis, gennaio 2013, DOI:10.1136/annrheumdis-2012-202760, PMID 23313811.

nih.gov (Global: 4^th place; Italian: 9^th place)

ncbi.nlm.nih.gov

DJ. Wallace, K. Kalunian; MA. Petri; V. Strand; FA. Houssiau; M. Pike; B. Kilgallen; S. Bongardt; A. Barry; L. Kelley; C. Gordon, Efficacy and safety of epratuzumab in patients with moderate/severe active systemic lupus erythematosus: results from EMBLEM, a phase IIb, randomised, double-blind, placebo-controlled, multicentre study., in Ann Rheum Dis, gennaio 2013, DOI:10.1136/annrheumdis-2012-202760, PMID 23313811.

web.archive.org (Global: 1^st place; Italian: 1^st place)

(EN) UCB and Immunomedics Announce Positive Results for Epratuzumab Phase IIb Study in... | Reuters, su reuters.com (archiviato dall'url originale il 14 novembre 2012).

Epratuzumab (Italian Wikipedia)

aacrjournals.org (Global: 8,869th place; Italian: 7,853rd place)

clincancerres.aacrjournals.org

archive.org (Global: 6th place; Italian: 8th place)

cancer.gov (Global: 1,684th place; Italian: 2,574th place)

doi.org (Global: 2nd place; Italian: 7th place)